Ventus Therapeutics U.S., Inc. Patent Application Trends in 2024

Ventus Therapeutics U.S., Inc. patent applications in 2024

Top 10 Technology Areas

• C07D471/04 (Ortho-condensed systems)
  • Count: 5 patents
  • Example: 20240158396. COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF simplified abstract (Ventus Therapeutics U.S., Inc.)
• C07D405/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 2 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• C07D491/048 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 2 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• C07D495/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 2 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• A61K31/501 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• A61K31/502 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• A61K31/5025 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• A61K31/5377 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• C07D519/00 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240174668. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)

Emerging Technology Areas

Error creating thumbnail: File missing

• C07D519/00 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 1 patents
  • Example: 20240174668. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• A61K31/5377 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• A61K31/5025 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• A61K31/502 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• A61K31/501 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
  • Count: 1 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• C07D495/04 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 2 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• C07D491/048 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 2 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• C07D405/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
  • Count: 2 patents
  • Example: 20240199606. PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3 simplified abstract (Ventus Therapeutics U.S., Inc.)
• C07D471/04 (Ortho-condensed systems)
  • Count: 5 patents
  • Example: 20240158396. COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF simplified abstract (Ventus Therapeutics U.S., Inc.)

Top Inventors

Error creating thumbnail: File missing

• Stéphane DORICH (4 patents)
• Amandine CHEFSON (4 patents)
• Jason BURCH (3 patents)
• Miguel ST-ONGE (3 patents)
• Alexandre CÔTÉ (3 patents)
• Stéphane CIBLAT (3 patents)
• Ramsay BEVERIDGE (2 patents)
• Lee Fader (1 patent)
• Jason Burch (1 patent)
• Miguel St-Onge (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors

Ventus Therapeutics U.S., Inc. Inventor States 2024 - Up to June 2024